34 companies have filed to go public in the US
Anthropic filed its S-1 on 26 Oct 2026. Since 26 Oct 2025, 93 companies have priced their IPO and raised $129 billion, led by Space Exploration Technologies ($75.0 billion in Jun 2026).
Headlines
- Waiting to list
- 34
- Filed, not priced yet
- Listed in the last year
- 93
- Priced since 26 Oct 2025
- Raised
- $129B
- IPO price times shares sold
- Above their IPO price
- 30 of 86
- At the latest close
Anthropic's S-1
Anthropic is a research lab focused on the responsible development and maintenance of advanced AI for the long-term benefit of humanity, delivering its frontier AI model Claude through models, platform, and applications.
Filed 26 Oct 2026
- Revenue, 2025
- $4.6B
- 12 times 2024
- Revenue, First half of 2026
- $16.3B
- 14 times a year earlier
- Operating loss, First half of 2026
- $693M
- $8.1B loss in 2025
- Net loss, First half of 2026
- $80.7B
- $80.1B of it outside operations
Revenue
- Listing
- Nasdaq Global Select Market, ANT
- Price range
- Not set yet
- Lead underwriters
- Goldman Sachs & Co. LLC, Morgan Stanley and J.P. Morgan
- Share classes
- Class A: 1 vote, Class N: 0 votes, Class T: 0 votes, Class E: 1 vote on limited matters, Class F: 50.1% of total voting power
- Employees
- 5,300
- Headquarters
- San Francisco, California
IPOs priced each month
Companies registering $100 million or more. Oct 2026 so far.
Up to 26 Oct 2026
| Month | IPOs | Raised |
|---|---|---|
| Nov 2025 | 5 | $1.6B |
| Dec 2025 | 5 | $7.6B |
| Jan 2026 | 6 | $2.1B |
| Feb 2026 | 12 | $4.1B |
| Mar 2026 | 4 | $1.5B |
| Apr 2026 | 10 | $6.2B |
| May 2026 | 11 | $10.2B |
| Jun 2026 | 13 | $83.5B |
| Jul 2026 | 11 | $7.5B |
| Aug 2026 | 6 | $1.6B |
| Sep 2026 | 4 | $1.0B |
| Oct 2026 | 5 | $1.3B |
Filed to go public
Companies with an S-1 or F-1 on file that have not priced their shares yet, registering $100 million or more.
Filings up to 26 Oct 2026
| Anthropic ANT | 26 Oct 2026 | - |
| Windward Bio Group AG WWB | 23 Oct 2026 | - |
| Rezera RZRA | 21 Oct 2026 | - |
| Bambusa Therapeutics BBTX | 9 Oct 2026 | $15-$17 |
| Aspen Neuroscience ASPE | 9 Oct 2026 | $15-$17 |
| OPay Limited OPAY | 9 Oct 2026 | $19-$21 |
| vVARDIS Holding AG VVVV | 9 Oct 2026 | - |
| Centinel Spine Holdco CNTL | 7 Oct 2026 | - |
| DayOne Data Centers Limited DODC | 5 Oct 2026 | - |
| Georgia Banking Company GBC | 2 Oct 2026 | - |
| Med-X MXRX | 25 Sep 2026 | - |
| TFP Group Limited TFP | 25 Sep 2026 | - |
| Nscale Limited NSCL | 18 Sep 2026 | - |
| Oura OURA | 3 Sep 2026 | $40-$44 |
| SB Energy SBE | 1 Sep 2026 | - |
| The Wella Company WELA | 31 Aug 2026 | - |
| Bamboo Insurance Services BMB | 28 Aug 2026 | $18-$20 |
| Aggreko AGKO | 24 Aug 2026 | - |
| CoVolt Power KVLT | 21 Aug 2026 | - |
| BirchBioMed BRBM | 12 Aug 2026 | - |
Showing 20 of 34 companies
Listed in the last year
IPO price, money raised and how the shares have traded since, against the IPO price.
Closes up to 26 Oct 2026
| Lycia Therapeutics LYCA | 23 Oct 2026 | $318M | +58% |
| City Therapeutics CTY | 16 Oct 2026 | $200M | +16% |
| Iambic Therapeutics IAM | 15 Oct 2026 | $150M | -10% |
| TRex Bio TRXB | 9 Oct 2026 | $117M | +1% |
| Accelevation Holdings ACCV | 1 Oct 2026 | $540M | -28% |
| Roze AI RZAI | 28 Sep 2026 | - | - |
| ADARx Pharmaceuticals ADRX | 28 Sep 2026 | $446M | +7% |
| Orion180 Insurance Group OIG | 21 Sep 2026 | $240M | -24% |
| Electra Therapeutics ETRA | 18 Sep 2026 | $350M | -42% |
| Lyntris LYNX | 19 Aug 2026 | $298M | -37% |
| Londian Wason New Energy Tech FOIL | 14 Aug 2026 | $94M | -22% |
| Latigo Biotherapeutics LTGO | 7 Aug 2026 | $346M | -16% |
| BlossomHill Therapeutics BLSM | 7 Aug 2026 | $150M | -3% |
| Braveheart Bio BRVE | 6 Aug 2026 | $383M | +19% |
| Attovia Therapeutics ATTO | 5 Aug 2026 | $289M | -18% |
| Apnimed APMD | 31 Jul 2026 | $192M | +19% |
| Jersey Mike’s Subs JMKE | 31 Jul 2026 | $1.0B | -26% |
| Reformation REF | 30 Jul 2026 | $211M | +7% |
| Ionic Digital IOND | 28 Jul 2026 | - | - |
| Scribe Therapeutics SCTX | 27 Jul 2026 | $129M | +4% |
Showing 20 of 93 companies
About the data
- Companies listing their shares for the first time that priced since 26 Oct 2025, or filed an S-1 or F-1 with the SEC since then and have not priced yet. SPACs, mergers with SPACs, spin-offs, funds, bank conversions and offerings registering less than $100 million are left out.
- A deal is listed once its final prospectus (424B4) is filed. 7 withdrawn deals are not shown.
- Terms and financials are read from each company's newest prospectus. Registered is the amount the filing fee is paid on, often a placeholder before the price range is set.
- Raised is the IPO price times the shares sold, without the underwriters' option. First day and since IPO compare the first and latest close with the IPO price.